BPI
PTCT icon

BFC Planning, Inc.’s PTC Therapeutics PTCT Stock Holding History

BFC Planning, Inc.’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Hold
178
– – ﹤0.01% 2166
2026
Q1 		$12.1K Sell
178
-197
-53% -$14K ﹤0.01% 1946
2025
Q4 		$28.5K Buy
375
+14
+4% +$1.02K ﹤0.01% 1591
2025
Q3 		$22.2K Buy
+361
New +$18.8K ﹤0.01% 1524
2025
Q1 		– Sell
-75
Closed -$3.39K – 2727
2024
Q4 		$3.39K Buy
+75
New +$3.21K ﹤0.01% 2129

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

BFC Planning, Inc.'s PTCT Position: Q2 2026 in Review

BFC Planning, Inc. held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 178 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

BFC Planning, Inc. first reported a position in PTCT in Q4 2024 and has held it in 5 quarters since. The position peaked at $28.5K in Q4 2025. 384 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • BFC Planning, Inc. held 178 shares of PTC Therapeutics worth $14.5K as of Q2 2026.
  • BFC Planning, Inc. left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2166 holding.
  • BFC Planning, Inc. first reported a position in PTC Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • BFC Planning, Inc.'s PTC Therapeutics position peaked at $28.5K in Q4 2025.
  • 384 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.